HR6054-119

Introduced

To ensure that a fair percentage of Federal cancer research funds are dedicated to pediatric cancer research.

119th Congress Introduced Nov 17, 2025

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

Requires the President to ensure that the share of federal cancer research funding devoted to pediatric cancer research matches the share of the U.S. population under age 18.

Who Benefits and How

Pediatric cancer research programs and families seeking more research attention to childhood cancer could gain a guaranteed funding floor tied to the child share of the population.

Who Bears the Burden and How

Federal cancer research funding would have less allocation flexibility, and non-pediatric research programs could receive a smaller share of the overall cancer research budget.

Key Provisions

  • Requires a pediatric cancer research funding percentage for fiscal year 2026 and each subsequent fiscal year.
  • Ties that percentage to the ratio of U.S. residents under age 18 to the total population.
  • Uses Bureau of the Census population figures from the preceding fiscal year to calculate the share.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.

At a Glance

What This Bill Does

Requires the President to ensure that the share of federal cancer research funding devoted to pediatric cancer research matches the share of the U.S. population under age 18.

Key Policy Areas

Healthcare, Science & Space, Government Operations

Primary Purpose

Requires the President to ensure that the share of federal cancer research funding devoted to pediatric cancer research matches the share of the U.S. population under age 18.

Policy Domains

Healthcare Science & Space Government Operations

Main Provisions

Identified Gains
Contextual inference, no direct clause citation
  • Pediatric cancer research programs and families seeking more federal research emphasis on childhood cancer
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Identified Costs
Contextual inference, no direct clause citation
  • Non-pediatric cancer research programs that may receive a smaller share of total federal cancer research funds
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Legislative Progress

Introduced
Introduced Committee Passed
Nov 17, 2025

Mr. Fitzpatrick (for himself, Mr. Evans of Pennsylvania, Mr. Kelly …

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Research & Science
2 mentions across 1 clause
+1 positive -1 negative

Non-pediatric cancer research programs that could lose budget share under the earmark, Pediatric cancer researchers and institutions receiving a protected share of federal cancer research funding

Positive-direction: Pediatric cancer researchers and institutions receiving a protected share of federal cancer research funding

Negative-direction: Non-pediatric cancer research programs that could lose budget share under the earmark

Healthcare
1 mention across 1 clause
+1 positive

Families and children affected by pediatric cancer who could benefit from more research focus

1/2
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Science & Space Government Operations

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology